Navigation Links
3SBio Inc. Announces First Quarter 2008 Results
Date:5/14/2008

- Q1 2008 net revenues grew 56.8%, as compared to Q1 2007, to RMB55.5

million (US$7.9 million) - Q1 2008 operating income grew 22.4%, as compared to Q1 2007, to RMB14.2

million (US$2.0 million)

- Q1 2008 net income grew 22.3%, as compared to Q1 2007, to RMB 19.8

million (US$2.8 million)

SHENYANG, China, May 14 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the first quarter ended March 31, 2008.

First Quarter 2008 Financial Highlights:

-- Total net revenues increased 56.8% over the first quarter 2007 to

RMB55.5 million (US$7.9 million).

-- Net revenue from our flagship injectable recombinant human

erythropoietin ("EPO") products, marketed under our EPIAO brand,

increased 41.2% over the first quarter 2007 to RMB35.5 million (US$5.1

million).

-- Net revenue from our protein-based therapeutic recombinant human

thrombopoietin ("TPO") products, marketed under our TPIAO brand,

increased 103.8% over the first quarter 2007 to RMB15.4 million (US$2.2

million).

-- Operating income increased 22.4% over the first quarter 2007 to

RMB14.2 million (US$2.0 million).

-- Net income increased 22.3% over the first quarter 2007 to RMB19.8

million (US$2.8 million).

-- Net income per American Depositary Share ("ADS") for the first

quarter 2008 was RMB0.91 (US$0.13). Each ADS represents seven ordinary

<
'/>"/>
SOURCE 3SBio Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. 3SBio Inc. Schedules 2008 First Quarter Earnings Release on Wednesday, May 14, 2008
2. 3SBio Inc. Approves Share Repurchase Program
3. 3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer
4. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
5. 3SBio Inc. Announces Change to the Board of Directors
6. 3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
7. 3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
9. 3SBio Inc. To Present at the 19th Annual Piper Jaffray Health Care Conference
10. 3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007
11. 3SBio Inc. to Hold Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... FALLS, N.Y., Jan. 15, 2014   Niagara Thermal Products ... selected by Buffalo BioBlower Technologies LLC ("B3") as the ... Phase 2 award from the Army Corps of Engineers.  ... that kills all biological contaminants and destroys VOCs and ...
(Date:1/15/2014)... SAN JOSE, California , January 15, 2014 ... conjugates for cancer, today announced the appointment of Thomas C ... has over 20 years, development experience gained in the biotechnology ... "I am delighted to welcome Tom at this ...
(Date:1/15/2014)... , January 15, 2014 A study has ... on the Formula 1 track could help to tackle the ... Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) and ... provider Simplyhealth. Telemetry technology, which is inspired by ...
(Date:1/15/2014)... January 15, 2014 The Microcompetition with Foreign ... disease. One of these latent viruses is the Epstein Barr ... (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease that ... study found that RA patients have high concentrations of EBV ...
Breaking Biology Technology:Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... 11 Serica Technologies, Inc., a,growth-stage medical ... recently completed the first manufacturing run of ... Serica,s new headquarters in,Medford, MA, includes 22,000 ... as well as manufacturing and administrative,space. The ...
... on the nation,s obesity crisis by addressing ... associated with hunger and excess weight., SAN DIEGO, ... company, announced the launch of GenoTrim, a DNA-based,nutritional solution ... both standard weight reduction strategies and numerous,"gimmicks" have proven ...
... Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced ... Officer, will provide a corporate,presentation at the UBS ... 24, 2007 at 4:00 p.m. Eastern time. ... accessed by visiting the,Investors section of the Jazz ...
Cached Biology Technology:Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing 2Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing 3Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management 2Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management 3
(Date:4/24/2014)... of America (ESA) is very pleased to announce that ... Insect Science from the University of Wisconsin. , ... is an international, open-access, peer-reviewed journal that publishes papers ... other arthropods -- from the molecular to the ecological ... It is freely available to individuals and institutions, and ...
(Date:4/24/2014)... State University and the University of North Carolina at ... could help identify arterial plaque that is at high ... stroke. , At issue is the plaque that builds ... plaque are deemed "vulnerable," meaning that they are more ... heart attack or stroke. , "Existing state-of-the-art technologies are ...
(Date:4/24/2014)... clear liquid can bend light, acting as a lens. ... a new process to create inexpensive high quality lenses ... , Because they,re so inexpensive, the lenses can be ... detect diseases in the field, scientific research in the ... classrooms. , "What I,m really excited about is ...
Breaking Biology News(10 mins):ESA to publish the Journal of Insect Science 2New ultrasound device may add in detecting risk for heart attack, stroke 2Bake your own droplet lens 2Bake your own droplet lens 3
... reefs are on the decline, with over-harvesting and pollution ... the last two centuries. With a growing awareness ... coasts from storm damage, and providing habitat for other ... in order to better understand the organisms and offer ...
... the researchers surrounding Prof. Dr. Martina Havenith (Physical Chemistry II ... Communication in the prestigious American chemistry journal, the Journal ... reviewers evaluated the work as one of the top 5% ... Temperatures of minus 1.8 C should really be ...
... CAMBRIDGE, Mass. -- Scientists at Harvard University have found that ... circuits as those used in more mundane choices related to ... other animals, put together two critical pieces of information: How ... are the odds that they will happen, depending on one,s ...
Cached Biology News:Cement, the glue that holds oyster families together 2Cement, the glue that holds oyster families together 3Why fish don't freeze in the Arctic Ocean 2Major moral decisions use general-purpose brain circuits to manage uncertainty 2Major moral decisions use general-purpose brain circuits to manage uncertainty 3